VNDA - Vanda Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $9.34. This is a potential upside of $5.45 (140.1%) from yesterday's end of day stock price of $3.89.

Vanda Pharmaceuticals's activity chart (see below) currently has 51 price targets and 30 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.89% with an average time for these price targets to be met of 454.5 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 25-Feb-2022. First documented stock forecast 17-Jan-2013.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

12

$8.11 (208.48%)

24

2 years 1 months 3 days ago

2/4 (50%)

$0.82 (7.33%)

46

Hold

18

$14.11 (362.72%)

14

3 years 1 months 17 days ago

8/9 (88.89%)

$-0.67 (-3.59%)

235

Sell

7

$3.11 (79.95%)

12

4 years 12 days ago

4/4 (100%)

$-1.1 (-13.58%)

285

Buy

25

$20.66 (476.04%)

52

4 years 1 months 2 days ago

1/3 (33.33%)

$14.34 (78.91%)

446

Hold

17

$13.11 (337.02%)

26

4 years 8 months 3 days ago

4/6 (66.67%)

$4.73 (38.55%)

248

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VNDA (Vanda Pharmaceuticals) average time for price targets to be met?

On average it took 454.5 days on average for the stock forecasts to be realized with a an average price target met ratio 79.89

Which analyst has the current highest performing score on VNDA (Vanda Pharmaceuticals) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on VNDA (Vanda Pharmaceuticals)?

Derek Archila works at WELLS FARGO and has 3 price targets and 2 ratings on VNDA

Which analyst is the currently most bullish on VNDA (Vanda Pharmaceuticals)?

Charles Duncan with highest potential upside - $26.11

Which analyst is the currently most reserved on VNDA (Vanda Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - $3.11

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?